These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33822914)

  • 1. Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis.
    Ng AC
    J Crohns Colitis; 2021 Oct; 15(10):1774. PubMed ID: 33822914
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of tofacitinib treatment in ulcerative colitis.
    Panés J; Gisbert JP
    Gastroenterol Hepatol; 2019; 42(6):403-412. PubMed ID: 31101342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
    Sandborn WJ; Su C; Sands BE; D'Haens GR; Vermeire S; Schreiber S; Danese S; Feagan BG; Reinisch W; Niezychowski W; Friedman G; Lawendy N; Yu D; Woodworth D; Mukherjee A; Zhang H; Healey P; Panés J;
    N Engl J Med; 2017 May; 376(18):1723-1736. PubMed ID: 28467869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses.
    Pantavou K; Yiallourou AI; Piovani D; Evripidou D; Danese S; Peyrin-Biroulet L; Bonovas S; Nikolopoulos GK
    United European Gastroenterol J; 2019 Dec; 7(10):1285-1303. PubMed ID: 31839954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of Takayasu arteritis complicated by refractory ulcerative colitis successfully treated with tofacitinib.
    Sato S; Matsumoto H; Temmoku J; Fujita Y; Matsuoka N; Furuya M; Gunji N; Fujiwara T; Asano T; Onizawa M; Kobayashi H; Watanabe H; Ohira H; Migita K
    Rheumatology (Oxford); 2020 Jul; 59(7):1773-1775. PubMed ID: 31776552
    [No Abstract]   [Full Text] [Related]  

  • 6. Tofacitinib for the treatment of ulcerative colitis.
    Fernández-Clotet A; Castro-Poceiro J; Panés J
    Expert Rev Clin Immunol; 2018 Nov; 14(11):881-892. PubMed ID: 30285500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data.
    Varyani F; Argyriou K; Phillips F; Tsakiridou E; Moran GW
    Drug Des Devel Ther; 2019; 13():4091-4105. PubMed ID: 31819376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review.
    Jena A; Mishra S; Sachan A; Singh H; Singh AK; Sharma V
    Inflamm Bowel Dis; 2021 Aug; 27(9):e101-e103. PubMed ID: 33988233
    [No Abstract]   [Full Text] [Related]  

  • 9. Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry.
    Biemans VBC; Sleutjes JAM; de Vries AC; Bodelier AGL; Dijkstra G; Oldenburg B; Löwenberg M; van Bodegraven AA; van der Meulen-de Jong AE; de Boer NKH; Srivastava N; West RL; Römkens TEH; Horjus Talabur Horje CS; Jansen JM; van der Woude CJ; Hoekstra J; Weersma RK; van Schaik FDM; Hoentjen F; Pierik MJ;
    Aliment Pharmacol Ther; 2020 May; 51(9):880-888. PubMed ID: 32237087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis?
    Honap S; Pavlidis P; Irving PM
    Aliment Pharmacol Ther; 2021 Aug; 54(3):341-342. PubMed ID: 34236096
    [No Abstract]   [Full Text] [Related]  

  • 11. Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience.
    Kotwani P; Terdiman J; Lewin S
    J Crohns Colitis; 2020 Jul; 14(7):1026-1028. PubMed ID: 32020189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.
    Danese S; D'Amico F; Bonovas S; Peyrin-Biroulet L
    Inflamm Bowel Dis; 2018 Sep; 24(10):2106-2112. PubMed ID: 29697791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis.
    Bonovas S; Lytras T; Nikolopoulos G; Peyrin-Biroulet L; Danese S
    Aliment Pharmacol Ther; 2018 Feb; 47(4):454-465. PubMed ID: 29205421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tofacitinib in ulcerative colitis.
    Archer TP; Moran GW; Ghosh S
    Immunotherapy; 2016 May; 8(5):495-502. PubMed ID: 27140405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and Indirect Effects of Tofacitinib on Treatment Satisfaction in Patients with Ulcerative Colitis.
    Panés J; Su C; Bushmakin AG; Cappelleri JC; Healey P
    J Crohns Colitis; 2016 Nov; 10(11):1310-1315. PubMed ID: 27194530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review-Authors' Reply.
    Taxonera C; Olivares D; Alba C
    Inflamm Bowel Dis; 2021 Aug; 27(9):e107. PubMed ID: 33988242
    [No Abstract]   [Full Text] [Related]  

  • 17. First Oral Drug for Moderate-To-Severe Ulcerative Colitis.
    Aschenbrenner DS
    Am J Nurs; 2018 Sep; 118(9):22-23. PubMed ID: 30138199
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: tofacitinib in treatment-refractory ulcerative colitis-a single centre real-world experience in Australia. Authors' reply.
    Biemans VBC; Straatmijer T; Hoentjen F; Pierik MJ
    Aliment Pharmacol Ther; 2021 Aug; 54(4):534-535. PubMed ID: 34331810
    [No Abstract]   [Full Text] [Related]  

  • 19. Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme.
    Sandborn WJ; Panés J; Sands BE; Reinisch W; Su C; Lawendy N; Koram N; Fan H; Jones TV; Modesto I; Quirk D; Danese S
    Aliment Pharmacol Ther; 2019 Nov; 50(10):1068-1076. PubMed ID: 31599001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes.
    Panés J; Su C; Bushmakin AG; Cappelleri JC; Mamolo C; Healey P
    BMC Gastroenterol; 2015 Feb; 15():14. PubMed ID: 25651782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.